Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human G-Protein Coupled Receptor 30 ELISA Kit (AC3270)
Cat.#: ASET-1859
Specifications
Description Human G-Protein Coupled Receptor 30 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human G-Protein Coupled Receptor 30 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.26 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 8-128 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1386 Mouse NMDAR1 ELISA Kit (AC2797) Quantitative inquiry ASET-1298 Guinea Pig Insulin ELISA Kit (AC2709) Quantitative inquiry ASET-1123 Rat Calbindin ELISA Kit (AC2534) Quantitative inquiry ASET-2514 Human ABCA7 ELISA Kit (AC3925) Quantitative inquiry ASET-1986 Rabbit Oxytocin ELISA Kit (AC3397) Quantitative inquiry ASET-1992 Porcine BDNF ELISA Kit (AC3403) Quantitative inquiry ASET-1321 Human Dopamine Transporter ELISA Kit (AC2732) Quantitative inquiry ASET-2389 Human Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3800) Quantitative inquiry ASET-2001 Human BCS1L ELISA Kit (AC3412) Quantitative inquiry ASET-1899 Human Vimentin ELISA Kit (AC3310) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket